Anti-platelet therapy: phosphodiesterase inhibitors

Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease

(2011) Jung-Won Suh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aspirin Extrusion From Human Platelets Through Multidrug Resistance Protein-4–Mediated Transport

(2011) Teresa Mattiello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100® and Multiplate® whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo

(2011) Chae-Wook Kim et al.   THROMBOSIS RESEARCH

Effects of Tadalafil on Platelets and Endothelium in Patients With Erectile Dysfunction and Cardiovascular Risk Factors: A Pilot Study

(2010) Emiliano De Bon et al.   ANGIOLOGY

Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway

(2010) Prasanna K. Venkatesh et al.   CARDIOVASCULAR RESEARCH

Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension

(2010) Bryan G. Schwartz et al.   CIRCULATION

Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial Infarction

(2010) Young-Hoon Jeong et al.   Circulation-Cardiovascular Interventions

Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition

(2010) Fernanda C.F. Brito et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Addition of Cilostazol to Aspirin and a Thienopyridine for Prevention of Restenosis After Coronary Artery Stenting: A Meta-Analysis

(2010) Douglas L. Jennings et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Periprocedural Cilostazol Treatment and Restenosis after Carotid Artery Stenting: The Retrospective Study of In-Stent Restenosis after Carotid Artery Stenting (ReSISteR-CAS)

(2010) Hiroshi Yamagami et al.   Journal of Stroke & Cerebrovascular Diseases

Cilostazol augments the inhibition of platelet aggregation in clopidogrel low-responders

(2010) K. LEE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

(2010) Yukito Shinohara et al.   LANCET NEUROLOGY

Phosphodiesterase Inhibitors for Pulmonary Hypertension

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study

(2009) Yaling Han et al.   AMERICAN HEART JOURNAL

Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 andABCB1

(2009) Hee-Doo Yoo et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Phosphodiesterase 2 Mediates Redox-Sensitive Endothelial Cell Proliferation and Angiogenesis by Thrombin via Rac1 and NADPH Oxidase 2

(2009) Isabel Diebold et al.   CIRCULATION RESEARCH

Stroke Prevention by Cilostazol in Patients with Atherothrombosis: Meta-analysis of Placebo-controlled Randomized Trials

(2009) Shinichiro Uchiyama et al.   Journal of Stroke & Cerebrovascular Diseases

Cilostazol reduces restenosis after carotid artery stenting

(2009) Tomoji Takigawa et al.   JOURNAL OF VASCULAR SURGERY

Translational Therapeutics of Dipyridamole

(2008) Hyung-Hwan Kim et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

(2008) Hans-Christoph Diener et al.   LANCET NEUROLOGY

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

(2008) Ralph L. Sacco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA

(2008) Piero Verro et al.   STROKE

Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

(2008) Robert J. Adams et al.   STROKE

Potentiation and priming of platelet activation: a potential target for antiplatelet therapy

(2008) Paolo Gresele et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Dipyridamole, cerebrovascular disease, and the vasculature

(2008) Subrata Chakrabarti et al.   VASCULAR PHARMACOLOGY